Statements (49)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:physicist
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:cyclophosphamide
|
| gptkbp:brand |
Rayos
Deltasone |
| gptkbp:contraindication |
systemic fungal infections
live vaccines hypersensitivity to prednisone |
| gptkbp:developed_by |
cortisone
|
| gptkbp:discovered_by |
gptkb:1955
|
| gptkbp:dosage_form |
10 mg
5 mg 20 mg 60 mg 40 mg |
| gptkbp:duration |
short-term
long-term |
| https://www.w3.org/2000/01/rdf-schema#label |
prednisone
|
| gptkbp:ingredients |
C21 H26 O5
|
| gptkbp:interacts_with |
anticoagulants
diuretics antidiabetic medications NSAI Ds |
| gptkbp:is_available_on |
gptkb:software_framework
gptkb:tablet suspension injection |
| gptkbp:is_monitored_by |
blood pressure
bone density blood sugar |
| gptkbp:is_used_for |
allergic reactions
autoimmune diseases inflammation certain cancers |
| gptkbp:lifespan |
3 to 4 hours
|
| gptkbp:manager |
oral
injectable |
| gptkbp:metabolism |
liver
|
| gptkbp:side_effect |
insomnia
weight gain increased appetite mood changes high blood sugar |
| gptkbp:symptoms |
fatigue
nausea fever joint pain muscle stiffness |
| gptkbp:type_of |
53-03-2
|